May 2nd, 2013
•We describe a valuable diagnostic assay that could potentially be used to decide the withdrawal of immunosuppression after transplant without elevated risk of graft rejection. The assay uses the principles of Delayed Type Hypersensitivity and provides accurate assessment of both donor specific effector and regulatory immune responses mounted by recipients.
Tags
Vídeos Relacionados
Antigen Specific In Vivo Killing Assay using CFSE Labeled Target Cells
Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity
Flow Cytometric Isolation of Primary Murine Type II Alveolar Epithelial Cells for Functional and Molecular Studies
Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
Detection and Enrichment of Rare Antigen-specific B Cells for Analysis of Phenotype and Function
In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados